Phase 3 Readout
UTMD: Phase 3 Topline: Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus
April 1, 2031. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- April 1, 2031
- Company
- Utah Medical Products Inc. (UTMD)
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 3 Readout~month
Phase 3 Topline: Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus
- Indication
- Esophageal Stricture